# Mastitis Control Programs in Dairy Herds: Monitoring and Prevention ## Key Takeaways - Mastitis control hinges on two objectives: reducing new intramammary infections and shortening the duration of existing ones, with pathogen profile dictating intervention priority. Contagious pathogens (*Staph. aureus*, *Strep. agalactiae*) are managed via milking hygiene and segregation, while environmental pathogens (*E. coli*, *Strep. uberis*) require focus on housing and cow comfort. - Herd-level monitoring integrates somatic cell count (SCC) trends (monthly composite SCC below 150,000 cells/mL is achievable) and clinical mastitis incidence rates (target < 5 cases per 100 cow-months). Bulk tank milk cultures are crucial for detecting contagious pathogens, but repeat sampling is necessary due to intermittent shedding. - *Staphylococcus aureus* infections have low cure rates influenced by cow age, SCC, infection duration, and quarter affected; culling chronically infected cows is often more cost-effective than repeated treatment. Coagulase-negative staphylococci (CNS) are the primary cause of heifer mastitis around parturition, typically benign and not requiring aggressive intervention. - The standard control program includes post-milking teat disinfection (a core component for contagious pathogen reduction), dry cow therapy (selected based on herd pathogen profile), and regular milking machine maintenance to prevent teat end damage. - Environmental mastitis, increasingly prevalent even in low-SCC herds, necessitates supplementary measures beyond the standard program, focusing on bedding hygiene, stocking density, and calving area cleanliness to mitigate exposure to pathogens like *E. coli* and *Streptococcus uberis*. - Accurate record-keeping of clinical mastitis events, SCC data, and culture results is paramount for trend analysis, enabling early detection of failure modes such as silent re-infection cycles or rising environmental pathogen pressure. --- Mastitis remains the most frequent disease of dairy cows and a primary driver of economic loss through reduced yield, milk quality penalties, and compromised animal welfare. This article provides a herd-level framework for mastitis control, covering the scientific basis of infection dynamics, monitoring parameters, and preventive strategies. It is written for practicing veterinarians who design, audit, or refine udder health programs and who require decision criteria grounded in published evidence. Clinical treatment of individual cases is excluded, the focus is on preventing new intramammary infections and shortening the duration of existing ones across the herd. Effective control rests on two complementary objectives: reducing the rate at which new infections occur and reducing the time cows remain infected. These principles were established decades ago and remain the structural logic of every modern control program. The pathogen profile of a herd determines which interventions carry the highest priority, and the monitoring system determines whether those interventions are working. ## At a Glance | Parameter or Decision | Clinical Relevance | Reference Point | | --- | --- | --- | | Herd somatic cell count (SCC) | Indicates prevalence of subclinical infection | Use monthly composite SCC trends, not single samples | | Individual cow SCC | Identifies chronically infected cows for culling or dry-off decisions | Rising SCC with age and infection duration lowers cure probability | | Bulk tank milk culture | Detects contagious pathogens such as *Staph. aureus* and *Strep. agalactiae* | Repeat sampling needed to rule out intermittent shedding | | Clinical mastitis incidence rate | Tracks environmental pathogen pressure | Calculate cases per 100 cow-years | | Post-milking teat disinfection | Reduces contagious pathogen transmission | Core component of the standard control program | | Dry cow therapy | Eliminates existing infections and prevents new ones in the dry period | Select product based on herd pathogen profile | | Milking machine function | Affects teat condition and infection risk | Evaluate vacuum stability and liner condition regularly | | Heifer udder health | CNS infections around parturition are common and usually benign | Monitor separately from the milking herd | ## The Scientific Foundation of Mastitis Control Mastitis is the inflammatory response of the mammary gland to infection, most commonly bacterial. The pathogens responsible are conventionally divided into contagious and environmental categories. Contagious pathogens, including *Staphylococcus aureus*, *Streptococcus agalactiae*, and *Mycoplasma* species, are transmitted primarily during milking. Environmental pathogens, including *Escherichia coli* and *Streptococcus uberis*, are acquired from the cow's surroundings between milkings. This distinction matters because the control measures differ: contagious pathogens are managed through milking-time hygiene and segregation, whereas environmental pathogens require attention to bedding, housing, and cow comfort. The epidemiology of mastitis has shifted over recent decades. Widespread implementation of control programs has dramatically reduced the incidence of clinical mastitis, but the relative importance of different pathogens has changed. *E. coli* and *Strep. uberis* are now the two most common causes of bovine mastitis and are an increasing problem in low somatic cell count herds. This shift has important implications for monitoring, because herds with excellent contagious pathogen control can still experience unacceptable rates of clinical disease from environmental sources. ## Pathogen-Specific Considerations ### Staphylococcus aureus *Staph. aureus* is an important cause of udder infections in dairy herds and presents particular challenges for control. The probability of cure depends on cow, pathogen, and treatment factors. Cure rates decrease with increasing age of the cow, increasing somatic cell count, increasing duration of infection, increasing bacterial colony counts in milk before treatment, and increasing number of quarters infected. Hind quarter infections have a lower cure rate than front quarter infections. Antimicrobial treatment of intramammary infections with penicillin-resistant *Staph. aureus* strains results in a lower cure rate, whether treated with beta-lactam or non-beta-lactam antibiotics. The most important treatment factor affecting cure is treatment duration, extended treatment is associated with an increased chance of cure, although it is not always economically justified even when indirect effects such as prevention of contagious transmission are considered. For the control program, these findings mean that identifying and culling chronically infected cows is often more cost-effective than repeated treatment attempts. ### Coagulase-Negative Staphylococci in Heifers Heifer mastitis deserves separate attention within a herd program. Coagulase-negative staphylococci (CNS) are the predominant cause of intramammary infection and subclinical mastitis in heifers around parturition, whereas *Staph. aureus* and environmental pathogens cause a minority of cases. Clinical heifer mastitis is typically caused by the major pathogens. The variation in proportions of causative pathogens between studies, herds, and countries is considerable. Intramammary infection in early lactation caused by CNS does not generally have a negative effect on subsequent productivity. At the herd level, the impact of heifer mastitis depends on the prevalence and incidence of the disease, the nature of the problem, the causative pathogens involved, and the ability of the animals to cope with the infection. Control programs should therefore monitor heifer udder health separately from the milking herd and avoid aggressive intervention for CNS infections that are unlikely to affect future performance. ## The Standard Control Program The foundational control program, developed through decades of research, incorporates post-milking teat disinfection, treatment of clinical cases, dry cow therapy, culling of chronically infected cows, and regular milking machine maintenance. This program was designed to control contagious pathogens and remains the backbone of udder health management. Its success depends on consistent execution, which requires written protocols, staff training, and periodic auditing. The program does not address environmental pathogens with equal effectiveness, so herds with predominantly environmental mastitis require supplementary measures focused on bedding hygiene, stocking density, and calving area cleanliness. ## Antimicrobial Use and Resistance Antibiotic treatment is an established component of mastitis control programs, but the extensive use of antibiotics has increased concerns about the emergence of antibiotic-resistant pathogens. This has led the dairy industry to reduce antibiotic use and to seek alternative therapies, particularly natural products from plants and animals. The veterinarian's role includes selecting antimicrobials based on pathogen identity and susceptibility, avoiding treatment of infections with a low probability of cure, and using dry cow therapy selectively instead of universally where the evidence supports it. Current formulary and label references must be consulted for specific product choices, doses, and withdrawal periods, as these vary by jurisdiction and product. ## The Herd-Level Diagnostic Sequence Mastitis control begins with classification of the problem. A herd investigation should establish whether the dominant pattern is contagious transmission, environmental exposure, or a mixture of both. The distinction determines which control measures will be effective and which will fail. The sequence starts with bulk milk somatic cell count (BMSCC) and bulk milk culture. Bulk culture detects major contagious pathogens such as *Staphylococcus aureus* and *Streptococcus agalactiae* when they are shed by multiple cows, but it is insensitive for environmental organizms and for low-prevalence infections. A negative bulk culture does not exclude contagious mastitis. Individual cow cultures are required when bulk culture is negative but the epidemiological pattern suggests contagion. The next step is analysis of individual cow somatic cell counts (SCC) from the monthly Dairy Herd Improvement (DHI) or equivalent testing record. Cows with SCC above 200,000 cells/mL are likely infected. The distribution of high-SCC cows across lactations and calving dates indicates whether the problem is chronic infection in older cows, new infections in early lactation, or a dry period problem. A herd with high SCC concentrated in second and later lactations has a chronic infection problem. A herd with elevated SCC in first lactation heifers has a prepartum or heifer-rearing problem, and the evidence base for heifer mastitis control differs from that for adult cows [De Vliegher et al., heifer mastitis review](https://pubmed.ncbi.nlm.nih.gov/22365187/). Clinical mastitis incidence is tracked separately from SCC. The two parameters can move independently. A herd can have low BMSCC and high clinical mastitis incidence, which typically indicates environmental pathogens, particularly *Escherichia coli* and *Streptococcus uberis* [Bradley, bovine mastitis as an evolving disease](https://pubmed.ncbi.nlm.nih.gov/12359466/). Conversely, high BMSCC with low clinical incidence suggests chronic contagious infection. ## Interpreting Somatic Cell Count Data BMSCC is a regulatory and marketing parameter in most dairy regions, and it reflects the prevalence of subclinical infection in the milking herd. Monthly BMSCC values below 150,000 cells/mL are achievable in well-managed herds. Values above 250,000 cells/mL indicate that contagious transmission is likely occurring and that the standard control program is not being fully applied. Individual cow SCC data provide more resolution. The key calculations are: - **Linear score (LS)**. The log-transformed SCC value used in genetic evaluations and most DHI reports. A change of one LS unit represents a doubling of SCC. Cows with LS above 4.0 (approximately 200,000 cells/mL) are considered infected. - **New infection rate**. The proportion of cows moving from low LS to high LS between consecutive tests. This estimates the incidence of new intramammary infections. - **Cure rate**. The proportion of high-LS cows returning to low LS without treatment. This estimates spontaneous cure and the effectiveness of dry cow therapy. - **Chronic infection prevalence**. The proportion of cows with high LS on two or more consecutive tests. These parameters should be calculated separately for first lactation and older cows. Heifers have lower baseline SCC than multiparous cows, and their infection dynamics differ. Coagulase-negative staphylococci dominate heifer infections around parturition, and these infections do not generally reduce subsequent productivity [De Vliegher et al., heifer mastitis review](https://pubmed.ncbi.nlm.nih.gov/22365187/). Treating every high-SCC heifer is therefore not always justified. ## Culture-Based Monitoring Bacteriological culture of milk samples is the definitive method for identifying the pathogens driving herd mastitis problems. Culture is indicated when: - BMSCC exceeds 200,000 cells/mL for two consecutive months - Clinical mastitis incidence exceeds 30 cases per 100 cow-years - The response to standard control measures is poor - Bulk milk culture detects a contagious pathogen Sampling strategy depends on the question. For clinical mastitis, culture all clinical cases for a defined period, typically 4 to 8 weeks, to establish the pathogen profile. For subclinical mastitis, culture a representative sample of high-SCC cows, usually 10 to 20 cows or all cows with LS above 4.0, depending on herd size. Composite samples from all four quarters are adequate for herd-level decisions. Quarter samples are required when the goal is to decide which quarters to treat or cull. The culture results should be interpreted in the context of the herd's SCC and clinical incidence data. A herd with high clinical incidence and a predominance of *E. coli* and *Strep. uberis* has an environmental problem. A herd with high BMSCC and a predominance of *Staph. aureus* has a contagious problem. Mixed patterns are common, and the control program must address both routes of transmission. ## The Monitoring Plan A practical monitoring plan integrates SCC, culture, and clinical records into a monthly or quarterly review cycle. The plan should generate specific action thresholds, not general impressions. | Parameter | Frequency | Action Threshold | Interpretation | Response | |---|---|---|---|---| | BMSCC | Monthly | > 200,000 cells/mL | Contagious transmission likely | Review milking routine, teat disinfection, dry cow therapy | | BMSCC | Monthly | > 400,000 cells/mL | Severe contagious problem | Individual cow cultures, segregation or culling of chronic shedders | | Clinical mastitis incidence | Monthly | > 5 cases per 100 cow-months | Environmental exposure or milking machine fault | Culture clinical cases, review bedding and premilking preparation | | New infection rate (LS) | Monthly | > 10% of cows per month | Control program failure | Audit milking routine, check teat condition, review dry cow management | | Cure rate (LS) | Monthly | < 40% | Chronic infections not resolving | Review treatment protocols, consider culling chronic cases | | Bulk milk culture | Quarterly | Any contagious pathogen | Active shedding | Identify and manage infected cows | The monitoring plan requires accurate records. Clinical mastitis events must be recorded with date, cow identification, quarter affected, and treatment given. SCC data must be downloaded and analyzed promptly after each test day. Culture results must be linked to the cow and quarter sampled. Without these records, the monitoring plan cannot distinguish new infections from chronic ones, and control decisions become guesswork. ## Prevention Checklist Prevention measures are organized around the two routes of transmission. Contagious pathogens are spread from cow to cow during milking. Environmental pathogens are acquired from the housing and bedding between milkings. **Milking routine and hygiene** - Pre-milking teat preparation. Fore-strip each cow, dry the teats with individual paper towels, and apply pre-milking teat disinfectant when environmental mastitis is a problem. Allow sufficient contact time before attaching the cluster. - Post-milking teat disinfection. Apply an effective teat dip to the full length of each teat after cluster removal. This is the single most effective measure against contagious transmission [Ruegg, 100-year review of mastitis detection and prevention](https://pubmed.ncbi.nlm.nih.gov/29153171/). - Milking machine function. Evaluate vacuum stability, pulsation, and liner condition at least twice yearly. Machine faults cause teat end damage that increases infection risk. - Milking order. Milk first lactation heifers and low-SCC cows before high-SCC cows when contagious pathogens are present. Segregate known infected cows where feasible. **Dry cow management** - Dry cow therapy. Treat all quarters of all cows at drying off with an appropriate dry cow antimicrobial product. Selective dry cow therapy, based on culture or SCC history, is an alternative in herds with low prevalence of contagious pathogens, but it requires accurate identification of infected cows [Gomes and Henriques, control of bovine mastitis](https://pubmed.ncbi.nlm.nih.gov/26687332/). - Teat sealants. Internal teat sealants provide a physical barrier against environmental pathogens during the dry period. They are particularly valuable in herds with dry period environmental mastitis problems. - Dry cow environment. Provide clean, dry, well-bedded housing for dry cows. Contamination of the teat end during the early dry period and the immediate prepartum period is a major risk factor for environmental mastitis. **Heifer management** Heifer mastitis control requires attention to the prepartum period. Coagulase-negative staphylococci are the predominant cause of intramammary infection in heifers around parturition, and their control depends on reducing exposure in the prepartum environment [De Vliegher et al., heifer mastitis review](https://pubmed.ncbi.nlm.nih.gov/22365187/). Fly control, clean calving areas, and proper nutrition are the main preventive measures. Antimicrobial treatment of heifers before calving is not routinely recommended. ## Decision Points That Change the Approach The correct control program depends on the pathogen profile, the herd's SCC history, and the available resources. A herd with a *Staph. aureus* problem requires a different approach from a herd with an *E. coli* problem. The cure rate for *Staph. aureus* mastitis decreases with increasing age, SCC, and duration of infection, so culling chronic shedders is often more cost-effective than extended treatment [Barkema et al., role of cow, pathogen, and treatment regimen in Staph. aureus mastitis](https://pubmed.ncbi.nlm.nih.gov/16702252/). In contrast, environmental mastitis is controlled primarily through hygiene and housing, not through cow-level interventions. The choice between blanket and selective dry cow therapy depends on the prevalence of subclinical infection. Blanket therapy is simpler and more effective in herds with high SCC. Selective therapy reduces antimicrobial use but requires reliable culture or SCC data to identify infected cows. The evidence base for selective therapy is stronger in herds with low BMSCC and low prevalence of contagious pathogens. Equipment availability also changes the approach. Herds without access to individual cow SCC data cannot calculate new infection rates or cure rates. Herds without on-farm culture capability must rely on bulk milk culture and clinical records. The monitoring plan must be adapted to the data that are actually available, and the veterinarian should identify which parameters are missing and what additional sampling is required to obtain them. ## Recognized Complications and Failure Modes Mastitis control programs fail through predictable pathways. The most common is the silent re-infection cycle, where a control program reduces clinical cases but subclinical transmission continues. This pattern emerges when the program emphasizes clinical detection while neglecting the dry period or the heifer population. Detection requires systematic culture of subclinical cases, not reliance on visible abnormalities alone. The second failure mode is the low somatic cell count herd with rising clinical mastitis, a pattern described in herds where control of contagious pathogens has succeeded but environmental exposure has increased [Bovine mastitis: an evolving disease](https://pubmed.ncbi.nlm.nih.gov/12359466/). The third is the persistent high cure-rate failure, where treatment protocols are sound but reinfection pressure from the environment or from undetected chronic carriers overwhelms the program. Early detection of these failure modes depends on trend analysis instead of point-in-time assessment. A single high bulk tank somatic cell count is less informative than a three-month trajectory. A rising proportion of cows with cell counts above 200,000 cells per mL in early lactation signals either inadequate dry cow therapy or fresh cow contamination. A rising clinical mastitis rate with stable cell counts points to environmental pathogens. The discriminating check is pathogen identification from clinical and subclinical cases, because the control measures differ fundamentally between contagious and environmental pathogens [A 100-Year Review: Mastitis detection, management, and prevention](https://pubmed.ncbi.nlm.nih.gov/29153171/). ## Common Errors in Program Design and Execution Less experienced clinicians often design a program around a single intervention, typically post-milking teat disinfection, while neglecting the other components of the standard control program. Corrective action is to audit all transmission routes: the milking routine, the milking machine function, the dry cow environment, and the calving area. A second error is interpreting bulk tank somatic cell count as a measure of udder health instead of as a screening tool. Bulk tank values are influenced by the proportion of infected cows, the stage of lactation, and the number of cows contributing milk. They cannot identify which cows are infected or which pathogens are involved. A third error is the failure to distinguish between cure and new infection when evaluating treatment outcomes. If a cow is treated and her cell count returns to normal, the clinician may assume cure. The cow may instead have cleared the infection spontaneously or may have been reinfected with a different strain. Discriminating between these possibilities requires culture before and after treatment, and where available, strain typing. A fourth error is the assumption that heifers are free of intramammary infection at calving. Coagulase-negative staphylococci are the predominant cause of intramammary infection in heifers around parturition, and their presence influences subsequent udder health [Invited review: Mastitis in dairy heifers: nature of the](https://pubmed.ncbi.nlm.nih.gov/22365187/). Programs that ignore the pre-calving heifer period leave a significant reservoir of infection unmanaged. ## Limitations of the Evidence and Areas of Expert Disagreement The evidence base for mastitis control is strong for the classic contagious pathogens but weaker for environmental pathogens. The control measures that proved effective against Streptococcus agalactiae and Staphylococcus aureus were developed over decades and are well validated [A 100-Year Review: Mastitis detection, management, and prevention](https://pubmed.ncbi.nlm.nih.gov/29153171/). For environmental pathogens such as Escherichia coli and Streptococcus uberis, the evidence is less definitive. These organizms are ubiquitous in the environment, and the relative importance of different exposure routes remains contested. Some experts emphasize bedding management, others milking routine, and others the dry period. The variation in pathogen profiles between herds and regions means that a program effective in one herd may fail in another [Invited review: Mastitis in dairy heifers: nature of the](https://pubmed.ncbi.nlm.nih.gov/22365187/). Expert opinion also differs on the role of treatment in control programs. The probability of cure for Staphylococcus aureus mastitis depends on cow, pathogen, and treatment factors, and extended treatment duration improves cure rates, but the economic justification for extended treatment is not always clear [Invited Review: The role of cow, pathogen, and treatment](https://pubmed.ncbi.nlm.nih.gov/16702252/). Some authorities advocate aggressive treatment of subclinical cases, while others argue that culling chronic carriers is more cost-effective. The evidence does not resolve this debate because the optimal strategy depends on herd-specific factors including prevalence, milk price, and replacement availability. ## Escalation and External Involvement Most mastitis control programs can be managed by the attending veterinarian. Referral or specialist consultation is warranted when the program fails to achieve targets despite correct execution, when unusual pathogens are isolated, or when the herd is part of a milk quality scheme with regulatory consequences. Mycoplasma mastitis, for example, requires a different control approach and may need laboratory confirmation. Regulatory reporting obligations vary by jurisdiction, and the veterinarian should confirm local requirements through the relevant animal health authority [USDA APHIS Animal Health Information](https://www.aphis.usda.gov/livestock-poultry-disease). International standards for surveillance and reporting are described in the terrestrial animal health code [WOAH Terrestrial Animal Health Code](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/). Laboratory involvement is indicated when bulk tank cultures are needed to identify herd-level pathogen profiles, when individual cow cultures are required to distinguish persistent infection from reinfection, and when antimicrobial susceptibility testing is needed for treatment planning. The decision to involve a diagnostic laboratory should be made early, because the cost of laboratory testing is small relative to the cost of a failed control program. | Observation | Likely Cause | Discriminating Check | |---|---|---| | Rising clinical mastitis, stable cell counts | Environmental pathogen exposure | Culture clinical cases, review bedding and calving area | | Rising cell counts, few clinical cases | Contagious transmission or chronic carriers | Culture subclinical cases, review milking routine | | High cure rate but no reduction in prevalence | Reinfection from environment or untreated reservoir | Culture before and after treatment, check dry cow therapy | | Low cell counts in heifers, high in older cows | Inadequate dry cow therapy or heifer management | Culture heifers pre-calving, review dry cow protocols | | Bulk tank cell count high, individual cow counts normal | Sampling error or laboratory issue | Repeat sampling, verify laboratory procedures | ## Frequently Asked Questions ### How Do I Prioritize Mastitis Control Actions When the Farm Has a Limited Budget? Start with interventions that reduce new infection pressure and contagious transmission. Post-milking teat disinfection and proper milking routine deliver the greatest return per dollar in most herds. Functional milking machine maintenance ranks next, followed by dry cow therapy decisions based on culture results. If culture-based selective therapy is unaffordable, continue blanket therapy while improving hygiene. Somatic cell count data from routine milk recording is the cheapest monitoring tool and should drive decisions before investing in on-farm culture. Reallocate spending from low-value interventions, such as frequent blanket antibiotic treatment of chronic high-cell-count cows, toward prevention. The [historical development of mastitis control programs](https://pubmed.ncbi.nlm.nih.gov/29153171/) shows that basic hygiene measures remain the foundation regardless of budget. ### What Is the Minimum Monitoring Protocol for a Herd Without Access to Routine Milk Recording? Use monthly bulk tank somatic cell count as the primary indicator. A rising bulk tank count signals increased infection prevalence or milk from clinically infected cows entering the tank. Perform California Mastitis Test screening on all cows at drying off and on fresh cows within one week of calving. Culture clinical cases and any cow with a positive California Mastitis Test and high somatic cell count estimate. Track the proportion of cows with elevated counts and the clinical mastitis incidence rate manually. Compare these figures against the previous month and the same month last year. [National animal health information resources](https://www.aphis.usda.gov/livestock-poultry-disease) can help identify regional benchmarks. This protocol detects major shifts in udder health even without electronic records. ### How Should I Explain a Mastitis Control Program to a Herd Owner Who Wants a Simple Summary? Frame the program around two questions: how many new infections occur and how long do cows stay infected. New infections come from the environment and from infected cows during milking. Duration of infection depends on cure rates and culling decisions. Explain that the milking routine, teat disinfection, and bedding management control new infections, while treatment decisions and culling control duration. Use the herd's own somatic cell count data to show progress. Emphasize that clinical mastitis is only the visible portion of the problem. The [changing pattern of mastitis pathogens](https://pubmed.ncbi.nlm.nih.gov/12359466/) means that environmental organizms now dominate in many low-cell-count herds, so bedding and premilking preparation deserve attention even when contagious pathogens are controlled. ### What Records Are Essential for Evaluating a Mastitis Control Program Over Time? Maintain a mastitis event log for every clinical case with date, cow identification, lactation number, affected quarter, and treatment given. Record culture results when available. Track monthly bulk tank somatic cell count and individual cow somatic cell count from milk recording. Calculate the clinical mastitis incidence rate per 100 cow-months and the proportion of cows with somatic cell count above 200,000 cells per mL. Record dry cow therapy protocols and culling reasons. Review these records quarterly to detect trends before problems become severe. [International standards for animal health surveillance](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/) emphasize consistent data collection for disease monitoring. Without written records, decisions rely on memory and clinical impression, which are unreliable for detecting gradual deterioration in udder health. ### How Does Mastitis Control Differ in Small Ruminant or Beef Herds? Lactating dairy sheep and goats share the same control principles but differ in pathogen profiles and management. Coagulase-negative staphylococci dominate in small ruminants, and contagious transmission occurs through shared milking clusters. Milking parlor hygiene and teat disinfection apply, but dry cow therapy is often impractical in seasonal systems. Beef cows rarely develop clinical mastitis, so control focuses on calf removal, fly control, and preventing trauma to the udder. The [review of heifer mastitis](https://pubmed.ncbi.nlm.nih.gov/22365187/) notes that pathogen distributions vary considerably between herds and production systems. Extrapolating dairy cattle protocols to other species requires adjustment for lactation length, milking frequency, and housing. Consult species-specific references such as the [MSD Veterinary Manual](https://www.msdvetmanual.com/) for adapted recommendations. ### When Should I Recommend Culling a Cow with Recurrent Mastitis Instead of Continuing Treatment? Cull when the cow has failed two or more treatments for the same quarter, has a somatic cell count above 400,000 cells per mL for more than two consecutive tests, or has chronic Staphylococcus aureus infection in multiple quarters. [Cure rates for Staphylococcus aureus mastitis](https://pubmed.ncbi.nlm.nih.gov/16702252/) decrease with increasing age, somatic cell count, duration of infection, and number of quarters infected. Consider the cow's production level, lactation number, and reproductive status. A high-producing young cow with a single affected quarter may justify one extended treatment, while an older cow with recurrent clinical episodes does not. Also consider the risk to herdmates. Chronic shedders perpetuate contagious transmission and undermine the entire control program. Discuss culling decisions with the owner using the herd's own records to make the economic case objective. ## Related Clinical & Scientific Guides * [Rumen Health Assessment in Dairy Cows: Clinical and Subclinical Indicators](/knowledge/veterinary-medicine/food-animal-medicine/rumen-health-assessment-dairy-cows-clinical-subclinical-indicators) * [Swine Nutrition and Health: Feed-Related Disease Diagnosis](/knowledge/veterinary-medicine/food-animal-medicine/swine-nutrition-health-feed-related-disease-diagnosis) * [Bovine Respiratory Disease Vaccine Selection: A Comparative Guide](/knowledge/veterinary-medicine/food-animal-medicine/bovine-respiratory-disease-vaccine-selection) ## References and Further Reading - [Invited Review: The role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Staphylococcus aureus mastitis.](https://pubmed.ncbi.nlm.nih.gov/16702252/). 2006. - [A 100-Year Review: Mastitis detection, management, and prevention.](https://pubmed.ncbi.nlm.nih.gov/29153171/). 2017. - [Invited review: Mastitis in dairy heifers: nature of the disease, potential impact, prevention, and control.](https://pubmed.ncbi.nlm.nih.gov/22365187/). 2012. - [Control of Bovine Mastitis: Old and Recent Therapeutic Approaches.](https://pubmed.ncbi.nlm.nih.gov/26687332/). 2016. - [Bovine mastitis: an evolving disease.](https://pubmed.ncbi.nlm.nih.gov/12359466/). 2002. - [Bovine mastitis: risk factors, therapeutic strategies, and alternative treatments - A review.](https://pubmed.ncbi.nlm.nih.gov/32777908/). 2020. - [USDA APHIS Animal Health Information](https://www.aphis.usda.gov/livestock-poultry-disease). USDA APHIS. - [FAO Animal Production and Health](https://www.fao.org/animal-production/en/). FAO. - [MSD Veterinary Manual, Professional Edition](https://www.msdvetmanual.com/). MSD Veterinary Manual. ## Related Articles - [Dairy Cow Hoof Health: Trimming Programs and Lesion Monitoring](/knowledge/veterinary-medicine/food-animal-medicine/dairy-cow-hoof-health-trimming-programs-lesion-monitoring) - [Dairy Cow Heat Stress: Monitoring and Mitigation Strategies](/knowledge/veterinary-medicine/food-animal-medicine/dairy-cow-heat-stress-monitoring-mitigation-strategies) - [Dairy Cow Monitoring Systems: Data Integration for Herd Health](/knowledge/veterinary-medicine/food-animal-medicine/dairy-cow-monitoring-systems-data-integration) - [Diagnostic Approach to Mastitis in Dairy Cows: Pathogen Identification and Herd Patterns](/knowledge/veterinary-medicine/food-animal-medicine/diagnostic-approach-mastitis-dairy-cows-pathogen-identification) - [Transition Cow Monitoring Protocols for Subclinical Disease Detection](/knowledge/veterinary-medicine/food-animal-medicine/transition-cow-monitoring-protocols-subclinical-disease) > This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.